| Weight Loss | | |
| CBD may reduce appetite, promote fat browning, and improve metabolism by blocking CB1 receptors and enhancing mitochondrial activity. | PMC: Phytocannabinoids & Obesity |
| THCV shows potential as an appetite suppressant and may help regulate blood sugar and insulin resistance. | PMC: Phytocannabinoids & Obesity |
| CBD’s anti-inflammatory effects may improve insulin sensitivity, supporting weight management. | Forbes Health: CBD for Weight Loss |
| CBG and CBDV are emerging as candidates for metabolic and appetite regulation, but more research is needed. | PMC: Phytocannabinoids & Obesity |
| Eye Health | | |
| CBD’s anti-inflammatory and neuroprotective properties may benefit diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD) by reducing oxidative stress and protecting retinal cells. | PMC: CBD Ocular Therapeutics |
| Topical CBD formulations are being studied for dry eye disease and corneal health, with potential to reduce inflammation and pain. | PMC: Cannabinoid-Based Ocular Therapies |
| CBD does not lower intraocular pressure like THC, but its neuroprotective effects may still support retinal health. | Eye Health Institute: CBD for Vision |
| Nanotechnology-based CBD delivery systems (e.g., nanoparticles) are being developed to improve efficacy in treating eye diseases. | PMC: Cannabinoid-Based Ocular Therapies |
| Challenges | | |
| The American Academy of Ophthalmology does not endorse CBD or cannabis for glaucoma due to limited evidence. | Dr. Dodge: Marijuana and the Eyes |
| More clinical trials are needed to confirm CBD’s efficacy and safety for weight loss and eye health. | Forbes Health: CBD Statistics |
